Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/Core EBITDA

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 21.4915.4015.663.982.20

What is the latest EV/Core EBITDA ratio of PIRAMAL PHARMA ?

The latest EV/Core EBITDA ratio of PIRAMAL PHARMA is 21.49 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.49
Mar202415.40
Mar202315.66
Mar20223.98
Mar20212.20

How is EV/Core EBITDA of PIRAMAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 21.49
39.55
Mar2024 15.4
-1.66
Mar2023 15.66
293.47
Mar2022 3.98
80.91
Mar2021 2.2 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/Core EBITDA ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,796.7 Cr -0.3% 1.2% -20.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,626.0 Cr 1.2% 4.4% -9.7% Stock Analytics
DIVIS LABORATORIES ₹180,669.0 Cr 5.8% 19.2% 16.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 1.4% 1.8% 10.8% Stock Analytics
CIPLA ₹122,103.0 Cr -3.7% -0.2% 1.6% Stock Analytics
DR REDDYS LABORATORIES ₹99,857.4 Cr -7.3% -4% -6.1% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0.3%

1.2%

-20.4%

SENSEX

-0.9%

4.6%

5%


You may also like the below Video Courses